|
2018-01-12 |
2018-01-09 |
PS
Planned sale
|
Katz Richard D
Vice President and CFO
Officer
|
104,435
-35.0%
0.16
USD 17,200
|
104,435
-35.0%
|
0.16
|
USD 17,200
|
|
|
2018-01-12 |
2018-01-09 |
PS
Planned sale
|
Harrelson Lori R.
Vice President of Finance
Officer
|
64,329
-21.8%
0.16
USD 10,595
|
64,329
-21.8%
|
0.16
|
USD 10,595
|
|
|
2018-01-12 |
2018-01-09 |
PS
Planned sale
|
Abbey Jeffrey D
President, CEO
Executive Director
|
124,987
-19.7%
0.16
USD 20,573
|
124,987
-19.7%
|
0.16
|
USD 20,573
|
|
|
2018-01-12 |
2018-01-09 |
PS
Planned sale
|
Nicolette Charles A.
CSO and Vice President of R&D
Officer
|
100,250
-20.0%
0.16
USD 16,501
|
100,250
-20.0%
|
0.16
|
USD 16,501
|
|
|
2018-01-05 |
2018-01-03 |
PS
Planned sale
|
Harrelson Lori R.
Vice President of Finance
Officer
|
59,072
-16.7%
0.16
USD 9,658
|
59,072
-16.7%
|
0.16
|
USD 9,658
|
|
|
2018-01-05 |
2018-01-03 |
PS
Planned sale
|
Abbey Jeffrey D
President, CEO
Executive Director
|
114,702
-15.3%
0.16
USD 18,719
|
114,702
-15.3%
|
0.16
|
USD 18,719
|
|
|
2018-01-05 |
2018-01-03 |
PS
Planned sale
|
Abbey Jeffrey D
President, CEO
Executive Director
|
114,702
-15.3%
0.16
USD 18,719
|
114,702
-15.3%
|
0.16
|
USD 18,719
|
|
|
2018-01-05 |
2018-01-03 |
PS
Planned sale
|
Katz Richard D
Vice President and CFO
Officer
|
101,228
-25.3%
0.16
USD 16,541
|
101,228
-25.3%
|
0.16
|
USD 16,541
|
|
|
2018-01-05 |
2018-01-03 |
PS
Planned sale
|
Nicolette Charles A.
CSO and Vice President of R&D
Officer
|
92,001
-15.5%
0.16
USD 15,061
|
92,001
-15.5%
|
0.16
|
USD 15,061
|
|
|
2016-10-13 |
2016-10-07 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
21,000
+0.2%
4.73
USD 99,330
|
21,000
+0.2%
|
4.73
|
USD 99,330
|
|
|
2016-10-13 |
2016-10-06 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
2,640
+0.0%
4.81
USD 12,698
|
2,640
+0.0%
|
4.81
|
USD 12,698
|
|
|
2016-10-13 |
2016-10-05 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
900
+0.0%
4.85
USD 4,365
|
900
+0.0%
|
4.85
|
USD 4,365
|
|
|
2016-10-13 |
2016-10-04 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
7,164
+0.1%
4.69
USD 33,599
|
7,164
+0.1%
|
4.69
|
USD 33,599
|
|
|
2016-10-04 |
2016-10-03 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
11,308
+0.1%
4.70
USD 53,148
|
11,308
+0.1%
|
4.70
|
USD 53,148
|
|
|
2016-10-04 |
2016-09-30 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
30,232
+0.2%
4.71
USD 142,393
|
30,232
+0.2%
|
4.71
|
USD 142,393
|
|
|
2016-09-30 |
2016-09-29 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
15,100
+0.1%
4.60
USD 69,460
|
15,100
+0.1%
|
4.60
|
USD 69,460
|
|
|
2016-09-30 |
2016-09-28 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
28,518
+0.2%
4.54
USD 129,472
|
28,518
+0.2%
|
4.54
|
USD 129,472
|
|
|
2016-09-21 |
2016-09-20 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
41,259
+0.3%
4.77
USD 196,805
|
41,259
+0.3%
|
4.77
|
USD 196,805
|
|
|
2016-09-21 |
2016-09-19 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
5,580
+0.0%
4.76
USD 26,561
|
5,580
+0.0%
|
4.76
|
USD 26,561
|
|
|
2016-09-20 |
2016-09-16 |
B
Purchase
|
Pharmstandard International S.A.
Large shareholder
|
36,632
+0.3%
4.78
USD 175,101
|
36,632
+0.3%
|
4.78
|
USD 175,101
|
|
